Week of 2026-08-31

Sixty-one trades were disclosed this week, headlined by a Pennsylvania senator's seventeen purchases of Goldman Sachs bonds and a Connecticut senator's multi-week exit from a small healthcare stock.

The Big Picture

This week's disclosures show highly concentrated activity from a small group of members. The standout pattern is Sen. Dave McCormick's repeated purchases of Goldman Sachs corporate bonds — a corporate bond is essentially a loan an investor makes to a company in exchange for regular interest payments, generally considered a more conservative instrument than buying the company's stock. On the selling side, healthcare dominated, with Sen. Richard Blumenthal systematically unwinding positions in a small biotechnology company over several weeks. Keep in mind that filings disclosed this week reflect trades made weeks earlier; the STOCK Act allows members up to 45 days between a transaction and its public disclosure.

This Week's Notable Trades

Dave McCormick (R-PA)

• Bought a $250,001–$500,000 position in The Goldman Sachs Group Inc (GS) corporate bonds on August 10 — the largest of 17 Goldman Sachs bond purchases all disclosed in a single filing on August 27, spanning trade dates from July 28 through August 19.
• Bought a second $250,001–$500,000 position in The Goldman Sachs Group Inc (GS) corporate bonds on August 18 — individual transaction amounts across the 17 purchases ranged from $50,001 to $500,000.
• Potential conflict: Sen. McCormick sits on the Senate Banking Committee, which holds direct oversight responsibility for major financial institutions, including Goldman Sachs. His repeated purchases of Goldman Sachs bonds represent a potential overlap between his committee jurisdiction and these personal investment decisions.

Richard Blumenthal (D-CT)

• Sold 32 positions in Alpha Teknova Inc (TKNO) — a small company that manufactures laboratory reagents used in biotechnology research — across multiple trading days from July 8 through July 16. Individual sale amounts ranged from $1,001–$15,000 to $15,001–$50,000 per transaction, indicating a systematic exit from the position.
• Also sold a $1,001–$15,000 position in CVRX Inc (CVRX), a medical device company that makes implantable devices for treating high blood pressure, on July 8.

Kelly Louise Morrison (D-MN)

• Sold multiple positions in Accenture PLC (ACN) — a large global technology consulting and professional services firm — on August 11, with per-transaction amounts ranging from $1,001–$15,000 to $15,001–$50,000.
• Sold two positions in Mobility Global Inc (MBGL), a small technology company, each in the $1,001–$15,000 range, on August 11.
• Sold a $1,001–$15,000 position in Solstice Advanced Materials Inc (SOLS), a basic materials company, on August 11.

Jared Moskowitz (D-FL)

• Bought a $1,001–$15,000 position in Applied Materials Inc (AMAT) — a major manufacturer of equipment used to produce semiconductors — on July 13.
• Sold a $1,001–$15,000 position in Steris PLC (STE), a company providing sterilization and surgical support products to the healthcare industry, on July 13.
• Sold a $1,001–$15,000 position in Grainger (W.W.) Inc (GWW), a large distributor of industrial and safety supplies, on July 13. All three Moskowitz transactions were disclosed 46 days after the trade date, just over the STOCK Act's 45-day limit.

Michael Rulli (R-OH)

• Sold a $50,001–$100,000 position in Alphabet Inc (GOOGL) — the parent company of Google — on August 24, with the filing submitted just two days later on August 26, well within the disclosure window.
• Potential conflict: Rep. Rulli serves on the House Committee on Energy and Commerce, which oversees telecommunications and technology policy — areas in which Alphabet is a leading participant. His sale of Alphabet stock represents a potential overlap between his committee jurisdiction and his personal portfolio activity.

By the Numbers

• Total trades disclosed: 61
• Party split: 43 Democratic, 18 Republican
• Most-bought sector: Financial Services (17 purchases, all Goldman Sachs corporate bonds)
• Most-sold sector: Healthcare (34 sales), driven largely by Sen. Blumenthal's Alpha Teknova liquidation
• Most active member: Sen. Richard Blumenthal (D-CT), with 33 disclosures
• Potential conflicts flagged: 18

Most significant potential conflicts this week:

• Sen. Dave McCormick (R-PA): Senate Banking Committee member disclosed 17 purchases of Goldman Sachs corporate bonds.
• Rep. Michael Rulli (R-OH): House Energy and Commerce Committee member disclosed a sale of Alphabet Inc stock.

Late to File

Under the STOCK Act, members must disclose trades within 45 days of the transaction date. This week's late filings:

• Sen. Richard Blumenthal (D-CT) — Alpha Teknova Inc (TKNO), multiple trades from July 8–10, each disclosed 47–49 days after the trade date; also CVRX Inc (CVRX), a July 8 trade, disclosed 49 days late.
• Rep. Jared Moskowitz (D-FL) — Applied Materials Inc (AMAT), Steris PLC (STE), and Grainger (W.W.) Inc (GWW), all traded July 13 and each disclosed 46 days later on August 28.

All-time: Across 22,267 total disclosures tracked in this database, 12.3% (2,731) were filed late. The members with the most cumulative late filings are Rep. Sheri Biggs (171), Rep. Julia Letlow (136), Rep. Valerie Hoyle (114), Sen. Thomas H. Tuberville (108), and Rep. Alan Armstrong (96). Late disclosure is a timing compliance matter, not an indication of wrongdoing.

The Fine Print

Data derived from public STOCK Act disclosures. Disclosure date is not the trade date (filings lag 30-45 days). Dollar figures are disclosed ranges, not exact amounts. Conflict-of-interest flags are heuristic "potential overlaps," not assertions of wrongdoing. Not investment advice.